Impact of central surgical review in a study of malignant germ cell tumors

Deborah F. Billmire, Frederick Rescorla, Jonathan H. Ross, Marc G. Schlatter, Bryan J. Dicken, Mark D. Krailo, Carlos Rodriguez-Galindo, Thomas A. Olson, John W. Cullen, A. Lindsay Frazier

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background Verification of surgical staging has received little attention in clinical oncology trials. Central surgical review was undertaken during a study of malignant pediatric germ cell tumors. Methods Children's Oncology Group study AGCT0132 included central surgical review during the study. Completeness of submitted data and confirmation of assigned stage were assessed. Review responses were: assigned status confirmed, assignment withheld pending review of additional information requested, or institutional assignment of stage disputed with explanation given. Changes in stage assignment were at the discretion of the enrolling institution. Results A total of 206 patients underwent central review. Failure to submit required data elements or need for clarification was noted in 40%. Disagreement with stage assignment occurred in 10% with 17/21 discordant patients reassigned to stage recommended by central review. Four ovarian tumor patients not meeting review criteria for Stage I remained in that stratum by institutional decision. Two-year event free survival in Stage I ovarian patients was 25% for discordant patients compared to 57% for those meeting Stage I criteria by central review. Conclusions Central review of stage assignment improved complete data collection and assignment of correct tumor stage at study entry, and allowed for prompt initiation of chemotherapy in patients determined not to have Stage I disease.

Original languageEnglish
Pages (from-to)1502-1505
Number of pages4
JournalJournal of Pediatric Surgery
Volume50
Issue number9
DOIs
StatePublished - Sep 1 2015

Fingerprint

Germ Cell and Embryonal Neoplasms
Medical Oncology
Disease-Free Survival
Neoplasms
Clinical Trials
Pediatrics
Drug Therapy

Keywords

  • Key words Malignant germ cell tumors
  • Surgical clinical trials
  • Surgical quality

ASJC Scopus subject areas

  • Surgery
  • Pediatrics, Perinatology, and Child Health

Cite this

Billmire, D. F., Rescorla, F., Ross, J. H., Schlatter, M. G., Dicken, B. J., Krailo, M. D., ... Frazier, A. L. (2015). Impact of central surgical review in a study of malignant germ cell tumors. Journal of Pediatric Surgery, 50(9), 1502-1505. https://doi.org/10.1016/j.jpedsurg.2014.12.008

Impact of central surgical review in a study of malignant germ cell tumors. / Billmire, Deborah F.; Rescorla, Frederick; Ross, Jonathan H.; Schlatter, Marc G.; Dicken, Bryan J.; Krailo, Mark D.; Rodriguez-Galindo, Carlos; Olson, Thomas A.; Cullen, John W.; Frazier, A. Lindsay.

In: Journal of Pediatric Surgery, Vol. 50, No. 9, 01.09.2015, p. 1502-1505.

Research output: Contribution to journalArticle

Billmire, DF, Rescorla, F, Ross, JH, Schlatter, MG, Dicken, BJ, Krailo, MD, Rodriguez-Galindo, C, Olson, TA, Cullen, JW & Frazier, AL 2015, 'Impact of central surgical review in a study of malignant germ cell tumors', Journal of Pediatric Surgery, vol. 50, no. 9, pp. 1502-1505. https://doi.org/10.1016/j.jpedsurg.2014.12.008
Billmire, Deborah F. ; Rescorla, Frederick ; Ross, Jonathan H. ; Schlatter, Marc G. ; Dicken, Bryan J. ; Krailo, Mark D. ; Rodriguez-Galindo, Carlos ; Olson, Thomas A. ; Cullen, John W. ; Frazier, A. Lindsay. / Impact of central surgical review in a study of malignant germ cell tumors. In: Journal of Pediatric Surgery. 2015 ; Vol. 50, No. 9. pp. 1502-1505.
@article{f6c5733bde4446dc82fe964affb2960f,
title = "Impact of central surgical review in a study of malignant germ cell tumors",
abstract = "Background Verification of surgical staging has received little attention in clinical oncology trials. Central surgical review was undertaken during a study of malignant pediatric germ cell tumors. Methods Children's Oncology Group study AGCT0132 included central surgical review during the study. Completeness of submitted data and confirmation of assigned stage were assessed. Review responses were: assigned status confirmed, assignment withheld pending review of additional information requested, or institutional assignment of stage disputed with explanation given. Changes in stage assignment were at the discretion of the enrolling institution. Results A total of 206 patients underwent central review. Failure to submit required data elements or need for clarification was noted in 40{\%}. Disagreement with stage assignment occurred in 10{\%} with 17/21 discordant patients reassigned to stage recommended by central review. Four ovarian tumor patients not meeting review criteria for Stage I remained in that stratum by institutional decision. Two-year event free survival in Stage I ovarian patients was 25{\%} for discordant patients compared to 57{\%} for those meeting Stage I criteria by central review. Conclusions Central review of stage assignment improved complete data collection and assignment of correct tumor stage at study entry, and allowed for prompt initiation of chemotherapy in patients determined not to have Stage I disease.",
keywords = "Key words Malignant germ cell tumors, Surgical clinical trials, Surgical quality",
author = "Billmire, {Deborah F.} and Frederick Rescorla and Ross, {Jonathan H.} and Schlatter, {Marc G.} and Dicken, {Bryan J.} and Krailo, {Mark D.} and Carlos Rodriguez-Galindo and Olson, {Thomas A.} and Cullen, {John W.} and Frazier, {A. Lindsay}",
year = "2015",
month = "9",
day = "1",
doi = "10.1016/j.jpedsurg.2014.12.008",
language = "English",
volume = "50",
pages = "1502--1505",
journal = "Journal of Pediatric Surgery",
issn = "0022-3468",
publisher = "W.B. Saunders Ltd",
number = "9",

}

TY - JOUR

T1 - Impact of central surgical review in a study of malignant germ cell tumors

AU - Billmire, Deborah F.

AU - Rescorla, Frederick

AU - Ross, Jonathan H.

AU - Schlatter, Marc G.

AU - Dicken, Bryan J.

AU - Krailo, Mark D.

AU - Rodriguez-Galindo, Carlos

AU - Olson, Thomas A.

AU - Cullen, John W.

AU - Frazier, A. Lindsay

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Background Verification of surgical staging has received little attention in clinical oncology trials. Central surgical review was undertaken during a study of malignant pediatric germ cell tumors. Methods Children's Oncology Group study AGCT0132 included central surgical review during the study. Completeness of submitted data and confirmation of assigned stage were assessed. Review responses were: assigned status confirmed, assignment withheld pending review of additional information requested, or institutional assignment of stage disputed with explanation given. Changes in stage assignment were at the discretion of the enrolling institution. Results A total of 206 patients underwent central review. Failure to submit required data elements or need for clarification was noted in 40%. Disagreement with stage assignment occurred in 10% with 17/21 discordant patients reassigned to stage recommended by central review. Four ovarian tumor patients not meeting review criteria for Stage I remained in that stratum by institutional decision. Two-year event free survival in Stage I ovarian patients was 25% for discordant patients compared to 57% for those meeting Stage I criteria by central review. Conclusions Central review of stage assignment improved complete data collection and assignment of correct tumor stage at study entry, and allowed for prompt initiation of chemotherapy in patients determined not to have Stage I disease.

AB - Background Verification of surgical staging has received little attention in clinical oncology trials. Central surgical review was undertaken during a study of malignant pediatric germ cell tumors. Methods Children's Oncology Group study AGCT0132 included central surgical review during the study. Completeness of submitted data and confirmation of assigned stage were assessed. Review responses were: assigned status confirmed, assignment withheld pending review of additional information requested, or institutional assignment of stage disputed with explanation given. Changes in stage assignment were at the discretion of the enrolling institution. Results A total of 206 patients underwent central review. Failure to submit required data elements or need for clarification was noted in 40%. Disagreement with stage assignment occurred in 10% with 17/21 discordant patients reassigned to stage recommended by central review. Four ovarian tumor patients not meeting review criteria for Stage I remained in that stratum by institutional decision. Two-year event free survival in Stage I ovarian patients was 25% for discordant patients compared to 57% for those meeting Stage I criteria by central review. Conclusions Central review of stage assignment improved complete data collection and assignment of correct tumor stage at study entry, and allowed for prompt initiation of chemotherapy in patients determined not to have Stage I disease.

KW - Key words Malignant germ cell tumors

KW - Surgical clinical trials

KW - Surgical quality

UR - http://www.scopus.com/inward/record.url?scp=84942549777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942549777&partnerID=8YFLogxK

U2 - 10.1016/j.jpedsurg.2014.12.008

DO - 10.1016/j.jpedsurg.2014.12.008

M3 - Article

C2 - 25783295

AN - SCOPUS:84942549777

VL - 50

SP - 1502

EP - 1505

JO - Journal of Pediatric Surgery

JF - Journal of Pediatric Surgery

SN - 0022-3468

IS - 9

ER -